News
NIH inventors have developed the first pharmacologic option for developmental stuttering, which is currently only managed by speech therapy, but addresses a $3 billion underserved global market. This technology uses small-molecule iron chelators – drugs that bind and remove excess iron – for the
The Office of Intramural Research (OIR), has created a new Web site at http://oir.nih.gov that consolidates information on the numerous programs and activities that OIR oversees. A prominent feature of this site is what has been known for many years as the NIH "Intramural Sourcebook", a compendium
A new funding opportunity announcement (FOA) is available to move commercially viable diagnostic inventions from NIAID and NIDDK intramural research laboratories into the marketplace. This FOA solicits Small Business Innovation Research (SBIR) grant applications for projects that further develop and
The OTT is pleased to announce that the annual report for Fiscal Year 2013 is now available for downloading. Click the icon below to download and view the report.